BioMarin Pharmaceutical Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2008 | $296.5M | $39.8M | $30.8M |
| FY2009 | $324.7M | $16.4M | $-488.0K |
| FY2010 | $376.3M | $544.0K | $205.8M |
| FY2011 | $441.4M | $-33.9M | $-53.8M |
| FY2012 | $500.7M | $-110.2M | $-114.3M |
| FY2013 | $548.5M | $-156.0M | $-176.4M |
| FY2014 | $749.3M | $-92.9M | $-134.0M |
| FY2015 | $889.9M | $-110.7M | $-171.8M |
| FY2016 | $1.12B | $-803.4M | $-630.2M |
| FY2017 | $1.31B | $-14.7M | $-117.0M |
| FY2018 | $1.49B | $-123.5M | $-77.2M |
| FY2019 | $1.70B | $-100.5M | $-23.8M |
| FY2020 | $1.86B | $-43.4M | $854.0M |
| FY2021 | $1.85B | $-82.3M | $-64.1M |
| FY2022 | $2.10B | $161.0M | $141.6M |
| FY2023 | $2.42B | $185.8M | $167.6M |
| FY2024 | $2.85B | $484.2M | $426.9M |
| FY2025 | $3.22B | $409.5M | $348.9M |